WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use

World Health Organization (WHO) preferred product characteristics describe preferences for product attributes that would help optimize value and use to address global public health needs, with a particular focus on low- and middle-income countries. Having previously published preferred product chara...

Descripción completa

Detalles Bibliográficos
Autores principales: Sparrow, Erin, Adetifa, Ifedayo, Chaiyakunapruk, Nathorn, Cherian, Thomas, Fell, Deshayne B., Graham, Barney S., Innis, Bruce, Kaslow, David C., Karron, Ruth A., Nair, Harish, Neuzil, Kathleen M., Saha, Samir, Smith, Peter G., Srikantiah, Padmini, Were, Fred, Zar, Heather J., Feikin, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176315/
https://www.ncbi.nlm.nih.gov/pubmed/35184927
http://dx.doi.org/10.1016/j.vaccine.2022.02.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176315/
https://www.ncbi.nlm.nih.gov/pubmed/35184927
http://dx.doi.org/10.1016/j.vaccine.2022.02.040

Ejemplares similares